Document is current
Any future updates will be listed below
-
Authors
Cannata-Andía, Jorge B. http://orcid.org/0000-0001-6543-9960
Díaz-Sottolano, Augusto
Fernández, Pehuén
Palomo-Antequera, Carmen
Herrero-Puente, Pablo
Mouzo, Ricardo
Carrillo-López, Natalia
Panizo, Sara
Ibañez, Guillermo H.
Cusumano, Carlos A.
Ballarino, Carolina
Sánchez-Polo, Vicente
Pefaur-Penna, Jacqueline
Maderuelo-Riesco, Irene
Calviño-Varela, Jesús
Gómez, Mónica D.
Gómez-Alonso, Carlos
Cunningham, John
Naves-Díaz, Manuel
Douthat, Walter
Fernández-Martín, José L.
,
- License Information
-
More Information
Article History
Received: 30 August 2021
Accepted: 9 February 2022
First Online: 18 February 2022
Declarations
:
: The ethics committees of all participating centre approved the study. Due to the COVID-19 pandemic and in order to avoid unnecessary exposure to the SARS-CoV-2 virus, all ethics committees authorized verbal consent. The trial was conducted according to the ethical principles of the Declaration of Helsinki.
: Not applicable.
: The following authors received research grants fees, grants for congress attending, courses and collaborations by the following entities: Jorge B. Cannata-Andía from Amgen, Kyowa-Kirim and Vifor Pharma; Ricardo Mouzo from Takeda, Otsuka, Nipro, Sanofi-Aventis, Amgen and the Senefro Foundation; Natalia Carrillo-López from Ministerio de Ciencia e Innovación (MICINN)/Instituto de Salud Carlos III (ISCIII); Sara Panizo from MICINN/ISCIII and Luis Hernando gran from Fundación Renal Íñigo Álvarez de Toledo; Carolina Ballarino from Pfizer, Takeda and Sanofi-Aventis; Jacqueline Pefaur-Penna from Novartis and Sanofi-Aventis; Jesús Calviño-Varela from Baxter, Otsuka, Palex, Astra, Vifor and Chiesi; Carlos Gómez-Alonso from Amgen, UCB, Stada, Grünenthal, Gebro Pharma, FAES, Kiowa-Kirin and Laboratorios Rubió; John Cunningham from Amgen, Merck and Vifor Pharma; Manuel Naves-Díaz from MICINN/ISCIII, Amgen, UCB, Kyowa-Kirim, Stada, Italfármaco, Gebro Pharma, Rubió, Gedeon Richter, Grünenthal and FEIOMM and José L. Fernández-Martín from MICINN/ISCIII. The rest of authors are not aware of any additional relationship, funding or financial holdings.
